Our researchers regularly share the results of their research. They are authors or co-authors of numerous scientific publications or presentations intended for a wider audience. You will find them below.
Use of PDXs and patient derived cell lines to uncover unconventional drug therapies and combinations for the treatment of drug resistant cancers
DOI: 10.1158/1538-7445.AM2018-2149 Published July 2018
CONTESSA TRIO: A Multinational, Multicenter, Phase 2 Study of Tesetaxel plus 3 Different PD-(L)1 Inhibitors in Patients with Metastatic Triple-Negative Breast Cancer (TNBC) and Tesetaxel Monotherapy in Elderly Patients with HER2- Metastatic Breast Cancer (MBC)
Patient and Patient Group Engagement in Cancer Clinical Trials: A Stakeholder Charter
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec